UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005707
Receipt number R000006733
Scientific Title Phase II study of R-CHOP and R-high-dose MTX therapy for untreated intravascular large B-cell lymphoma (PRIMEUR-IVL)
Date of disclosure of the study information 2011/06/03
Last modified on 2020/06/07 14:47:50

No. Disposal Last modified on Item of update
1 Insert 2011/06/02 17:02:51
2 Update 2011/08/19 11:40:18 Recruitment status
Last follow-up date
3 Update 2013/12/06 09:40:39 Email
Last name of contact person
Last name of contact person
TEL
Email
Name of person sending information
Name of person sending information
Address
Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2014/07/16 16:44:01 Last follow-up date
5 Update 2015/01/27 09:13:38 Interventions/Control_1
6 Update 2015/12/10 09:26:58 Email
7 Update 2017/01/16 10:05:36 UMIN ID1
8 Update 2017/01/16 10:11:24 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of primary person or sponsor
Organization
9 Update 2017/06/05 13:13:42 Recruitment status
10 Update 2018/07/02 23:53:58 Narrative objectives1
Narrative objectives1
11 Update 2018/07/02 23:56:44 Interventions/Control_1
Interventions/Control_1
12 Update 2018/07/03 00:00:35 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization1
Address1
Tel1
Email1
Institutions
13 Update 2019/04/13 11:27:16 UMIN ID2
14 Update 2019/04/13 11:36:13 Public title
Public title
Scientific Title
Scientific Title
15 Update 2019/04/13 11:53:42 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Homepage URL
Organization
Organization
Organization
Category of Funding Organization
Organization1
Tel1
Email1
Organization
Organization
Address
Address
Tel
Email
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
Institutions
16 Update 2019/04/13 11:55:28 URL releasing protocol
Number of participants that the trial has enrolled
17 Update 2019/04/13 12:08:30 Date of IRB
Anticipated trial start date
Last follow-up date
18 Update 2020/06/07 14:41:51 Recruitment status
19 Update 2020/06/07 14:42:48 Publication of results
URL related to results and publications
Results
Results
Results date posted
Date of the first journal publication of results
Adverse events
Adverse events
Outcome measures
Outcome measures
20 Update 2020/06/07 14:47:50 Publication of results